August 21, 2020: The Week in Cancer News
A combination of targeted therapies may be effective in people with bile duct cancers, and other cancer research news of the week selected by the staff of Cancer Today magazine.
Progress Against Cancer
A combination of targeted therapies may be effective in people with bile duct cancers, and other cancer research news of the week selected by the staff of Cancer Today magazine.
Most young cancer patients in the U.S. do not receive counseling about how chemotherapy could harm their chances of becoming parents before beginning the treatment.
Lung cancer death rates are on the decline and other cancer research news of the week selected by the staff of Cancer Today magazine.
A study showing the rates of anal cancer diagnoses and deaths rising in the U.S. underscores the importance of early detection and prevention.
The FDA approved the first liquid biopsy companion diagnostic that uses next-generation sequencing to test for EGFR gene mutations in certain types of lung cancer.
A study shows that new cancer diagnoses declined in March and April 2020, and other cancer research news of the week selected by the staff of Cancer Today magazine.
In a study, researchers found an association between periodontal disease, tooth loss, and conditions associated with colorectal cancer.
The FDA has approved the first targeted therapeutic against B-cell maturation antigen (BCMA) to treat certain patients with multiple myeloma.
New cervical cancer screening guidelines emphasize the role of HPV testing, a study shows a steep decline in health care visits by people with cancer this spring, and more cancer research news of the week from Cancer Today magazine.
The FDA has approved a new immunotherapeutic for treating certain adult patients with diffuse large B-cell lymphoma. The U.S. Food and Drug Administration (FDA) granted accelerated approval to a new targeted immunotherapeutic called tafasitamab-cxix...
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More